Tenet Healthcare (NYSE:THC) Q3 results:
Revenues: $4,568M (+1.8%).
Net loss: ($232M) (-999%); loss/share: ($2.24) (-999%). Amount of net loss driven by debt refinancing transaction.
Cash flow ops (9 mo.): $713M (-10.8%).
Q4 guidance: Revenue: $4.678B – 4.878B; net income: $15M – 110M; non-GAAP EBITDA: $749M – 849M; EPS: $0.14 – 1.04; non-GAAP EPS: $0.57 – 1.23.
2019 guidance: Revenue: $18.350B – 18.550B; net loss: ($230M – 135M); loss/share: ($2.23 – 1.31); non-GAAP EPS: $2.25 – 2.91; cash flow ops: $1.045B – 1.325B.
Previously: Tenet Healthcare EPS beats by $0.26, beats on revenue (Nov. 4)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.